US 12209085
RET inhibitors, pharmaceutical compositions and uses thereof
granted A61KA61K31/444A61K31/4545
Quick answer
US patent 12209085 (RET inhibitors, pharmaceutical compositions and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/444, A61K31/4545, A61K31/496, A61K31/497